Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1493302

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1493302

U.S. Defibrillator Market Size, Share & Trends Analysis Report By Product (Implantable Cardioverter Defibrillators, External Defibrillators), By End-Use (Hospital, Pre-hospital), And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 3950
Printable PDF (5-User License)
USD 4950
Printable PDF (Enterprise License)
USD 6950

Add to Cart

U.S. Defibrillator Market Growth & Trends:

The U.S. defibrillator market size is anticipated to reach USD 4.32 billion by 2030, exhibiting a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing technological advancements, rising incidence of sudden cardiac arrest and CVD's, rising adoption in emerging applications, and supportive initiatives by governments & healthcare organizations are some of the key factors fueling industry growth.

The escalating prevalence of cardiovascular diseases in the U.S. serves as a major driving force for the U.S. defibrillator market. For instance, as per the Centers for Disease Control and Prevention (CDC), around 454,000 hospitalizations annually in the U.S. involve Atrial Fibrillation (AFib) as the primary diagnosis. This health condition contributes to around 158,000 annual deaths. This rising trend of cardiovascular diseases is expected to contribute to market growth during the forecast period.

The rising geriatric population and technological advancements are expected to significantly impact market growth. Individuals aged 65 years and above are highly prone to chronic illnesses such as cardiovascular diseases (CVDs). For instance, a November 2022 article titled "Senior Population Statistics: A Portrait of Aging Americans" revealed that approximately 54.1 million (16.3%) people in the U.S. are 65 years or older. Consequently, the growing geriatric population drives the demand for these products.

U.S. Defibrillator Market Report Highlights:

  • Implantable cardioverter defibrillators (ICDs) dominated the market with a share of more than 50% in 2023. Key factors driving this segment growth include the rising adoption of these devices due to the high prevalence of CVDs, the high geriatric population in key markets, and growing product applications and technological advancement.
  • Hospital segment held the largest revenue share in 2023 owing to the higher volume of cardiac cases in hospitals and surgeries performed in hospital settings.
  • The public access market segment is anticipated to register the fastest CAGR from 2024 to 2030 due to the rising initiatives to increase the availability of public access AEDs.
  • Market players operating in the U.S. defibrillator market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Koninklijke Philips N.V., Stryker, ZOLL Medical Corporation (Asahi Kasei), Nihon Kohden Corporation, and Siemens Healthineers.
  • In February 2024, BIOTRONIK, a prominent company in the field of implantable medical devices, declared its decision to exclusively provide their innovative DX models for future single-chamber ICD implantations.
Product Code: GVR-4-68040-277-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-Use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Defibrillator Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing technological advancements
      • 3.2.1.2. Rising incidence of sudden cardiac arrest and CVD's
      • 3.2.1.3. Supportive initiatives by governments & healthcare organizations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
  • 3.3. U.S. Defibrillator Market Analysis Tools
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Supplier power
      • 3.2.3.2. Buyer power
      • 3.2.3.3. Substitution threat
      • 3.2.3.4. Threat of new entrant
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.3.1. Political landscape
      • 3.2.3.2. Technological landscape
      • 3.2.3.3. Economic landscape

Chapter 4. U.S. Defibrillator Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Defibrillator Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Implantable cardioverter defibrillators (ICD)
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. S-ICD
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. T-ICD
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.2. Single chamber
      • 4.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.3. Dual chanmber
      • 4.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.4. CRT-D
      • 4.4.1.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. External defibrillators
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Manual ED
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Automated ED
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Wearable cardoverter defribrillators
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Defibrillator Market: End-Use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Defibrillator Market by End-Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospital
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Pre-hospital
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Public access market
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Alternate care market
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Home healthcare
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Medtronic
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Koninklijke Philips N.V.
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Siemens Healthineers
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Abbott
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Boston Scientific Corporation
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. BIOTRONIK SE & Co. KG
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. MicroPort Scientific Corporation
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Nihon Kohden Corporation
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Stryker
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
Product Code: GVR-4-68040-277-4

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. defibrillators market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. defibrillators market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. defibrillators market: Market outlook
  • Fig. 9 U.S. defibrillators competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. defibrillators market driver impact
  • Fig. 14 U.S. defibrillators market restraint impact
  • Fig. 15 U.S. defibrillators market: Product movement analysis
  • Fig. 16 U.S. defibrillators market: Product outlook and key takeaways
  • Fig. 17 Implantable cardioverter defibrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 S-ICD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 T-ICD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Single chamber market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Dual chamber market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 CRT-D market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 External defibrillators estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Manual ED market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Automated ED market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Wearable cardioverter defribrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. defibrillators market: End-Use movement analysis
  • Fig. 28 U.S. defibrillators market: End use outlook and key takeaways
  • Fig. 29 Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Pre-hospital market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 31 Public access market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 32 Alternate care market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 33 Home healthcare market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 34 Market share of key market players - U.S. defibrillators market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!